ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,930,000 | +38.6% | 34,455 | +1.1% | 0.02% | +28.6% |
Q2 2021 | $4,277,000 | -4.8% | 34,080 | +2.8% | 0.01% | -12.5% |
Q1 2021 | $4,494,000 | +13.3% | 33,142 | +6.9% | 0.02% | +14.3% |
Q4 2020 | $3,968,000 | +5.2% | 31,017 | -7.5% | 0.01% | -6.7% |
Q3 2020 | $3,773,000 | +14.5% | 33,530 | -3.1% | 0.02% | +7.1% |
Q2 2020 | $3,296,000 | -25.5% | 34,598 | -29.7% | 0.01% | -33.3% |
Q1 2020 | $4,424,000 | +69.5% | 49,226 | 0.0% | 0.02% | +110.0% |
Q4 2019 | $2,610,000 | +17.1% | 49,226 | -12.7% | 0.01% | +11.1% |
Q3 2019 | $2,228,000 | -38.4% | 56,400 | -35.9% | 0.01% | -30.8% |
Q2 2019 | $3,615,000 | -11.8% | 88,000 | 0.0% | 0.01% | -13.3% |
Q1 2019 | $4,098,000 | +77.6% | 88,000 | +66.0% | 0.02% | +50.0% |
Q4 2018 | $2,308,000 | -23.9% | 53,000 | 0.0% | 0.01% | -9.1% |
Q3 2018 | $3,033,000 | +17.9% | 53,000 | 0.0% | 0.01% | +10.0% |
Q2 2018 | $2,572,000 | +24.1% | 53,000 | 0.0% | 0.01% | +25.0% |
Q1 2018 | $2,072,000 | -7.9% | 53,000 | 0.0% | 0.01% | -11.1% |
Q4 2017 | $2,249,000 | +13.7% | 53,000 | 0.0% | 0.01% | +12.5% |
Q3 2017 | $1,978,000 | +261.6% | 53,000 | +194.4% | 0.01% | +300.0% |
Q2 2017 | $547,000 | +14.9% | 18,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $476,000 | +3.7% | 18,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $459,000 | -29.5% | 18,000 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $651,000 | +6.4% | 18,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $612,000 | +28.8% | 18,000 | 0.0% | 0.00% | +50.0% |
Q1 2016 | $475,000 | -72.9% | 18,000 | -50.0% | 0.00% | -50.0% |
Q4 2015 | $1,756,000 | +292.0% | 36,000 | +100.0% | 0.00% | +100.0% |
Q3 2015 | $448,000 | -21.4% | 18,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $570,000 | -16.8% | 18,000 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $685,000 | -2.3% | 18,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $701,000 | +28.9% | 18,000 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $544,000 | -11.0% | 18,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $611,000 | – | 18,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |